← Leaderboards
Adriana V Zeevi
University Of Pittsburgh At Pittsburgh
$5,314,958
Attributed
$5,314,958
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980.6K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$5,314,958 · 2
By mechanism
P50$4,537,580 · 1
R01$777,378 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael S. Diamond$85,358,908
- Mary L Marazita$48,708,804
- Surinder Kumar Batra$34,830,369
- Pat R Levitt$42,762,313
- Stephen A Murray$43,730,323
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineHuman SubjectTransplant RejectionTransplantation ImmunologyGenetic PolymorphismClinical ResearchHomologous TransplantationMhc Class Ii AntigenLung TransplantationPolymerase Chain ReactionInhalation Drug AdministrationIsoantibodyMhc Class I AntigenBronchoscopyHuman Therapy EvaluationCellular ImmunityHumoral ImmunityEnzyme Linked Immunosorbent AssayDiagnostic Respiratory LavageHistocompatibilityArtificial ImmunosuppressionCyclosporinesAerosolsHeart Transplantation
Grant awards (8)
Genetic Contribution to Graft and Patient Outcomes$755,858
P50 · FY2008 · HL · contact PI
Genetic Contribution to Graft and Patient Outcomes$808,200
P50 · FY2007 · HL · contact PI
Genetic Contribution to Graft and Patient Outcomes$980,610
P50 · FY2006 · HL · contact PI
Genetic Contribution to Graft and Patient Outcomes$953,350
P50 · FY2005 · HL
Genetic Contribution to Graft and Patient Outcomes$1,039,562
P50 · FY2004 · HL
IMPACT OF AEROSOL CYCLOSPORINE IN LUNG TRANSPLANTATION$261,102
R01 · FY2002 · HL
IMPACT OF AEROSOL CYCLOSPORINE IN LUNG TRANSPLANTATION$259,297
R01 · FY2001 · HL
IMPACT OF AEROSOL CYCLOSPORINE IN LUNG TRANSPLANTATION$256,979
R01 · FY2000 · HL